COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Babraham Seminar > “Meis2 activation by Kdm2b-containing complexes”
“Meis2 activation by Kdm2b-containing complexes”Add to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Bobbie Claxton. If you would like to attend this seminar, please contact us to arrange site access Biography: Dr Haruhiko Koseki is currently Group Director of Laboratory for Developmental Genetics at RIKEN Center for Integrative Medical Sciences (IMS) and Deputy Director of the Center. After he obtained his M.D. and Ph.D. from Chiba University, he was appointed Assistant Professor in 1990 and then Associate Professor in 1997 at School of Medicine, Chiba University. While holding the position of Assistant Professor, he won one of the competitive Long-Term Fellowship from the Human Frontier Science Program Organization and did his postdoctoral research at Max Planck Institute of Immunobiology in Freiburg, Germany. In 1998 he was appointed Professor at Department of Molecular Embryology, Graduate School of Medicine, Chiba University and joined RIKEN in 2001. Research: The Developmental Genetics Research Group is pursuing a research program to elucidate the epigenetic regulation of organ development and stem cell functions by Polycomb group (PcG) proteins and DNA methylation mechanisms. Main Research Subjects: • Regulation of large scale chromatin structures by Polycomb • Chromatin dynamics associated with activation of Polycomb-repressed genes • Development for anti-tumor immunotherapy by using iPSC-derived NKT cells This talk is part of the Babraham Seminar series. This talk is included in these lists:Note that ex-directory lists are not shown. |
Other listsCambridge Environment Sidgwick Site Equalities Improvement Network Peptide Mini-Symposium Amnesty Education Society Cambridge (ESC)Other talksLeveraging the imaging power of the Beacon platform MOVED TO 28 JUNE 2018 It takes two to tango:platelet collagen receptor GPVI-dimer in thrombosis and clinical implications Domain Uncertainty Quantification TBC |